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ABSTRACT
Previous studies have shown that Vasohibin 1 (Vash1) is stimulated
by VEGFs in endothelial cells and that its overexpression interferes
with angiogenesis in vivo. Recently, Vash1 was found to mediate
tubulin detyrosination, a post-translational modification that is
implicated in many cell functions, such as cell division. Here, we
used the zebrafish embryo to investigate the cellular and subcellular
mechanisms of Vash1 on endothelial microtubules during formation
of the trunk vasculature. We show that microtubules within venous-
derived secondary sprouts are strongly and selectively detyrosinated
in comparison with other endothelial cells, and that this difference is
lost upon vash1 knockdown. Vash1 depletion in zebrafish specifically
affected secondary sprouting from the posterior cardinal vein,
increasing endothelial cell divisions and cell number in the sprouts.
We show that altering secondary sprout numbers and structure upon
Vash1 depletion leads to defective lymphatic vessel formation and
ectopic lymphatic progenitor specification in the zebrafish trunk.
KEY WORDS: Lymphangiogenesis, Vash1, Microtubules, Tubulin
detyrosination, Sprouting angiogenesis
INTRODUCTION
Blood vessel formation and patterning is essential for tissue growth
and homeostasis in vertebrate development and physiology.
Endothelial cells (EC) arising from the lateral plate mesoderm in
early embryonic development initially coalesce at the midline to
form the first arterial and venous structures. Subsequent sprouting
angiogenesis and remodelling expands and shapes the vascular tree
throughout the developing embryo (Hogan and Schulte-Merker,
2017; Potente et al., 2011). Complex morphogenic and cell
differentiation processes orchestrate formation of arteries, veins
and capillaries, as well as of the lymphatic vascular system.
The trunk vasculature in zebrafish embryos has served both
angiogenesis and lymphangiogenesis research as a powerful model
to observe, manipulate and mechanistically understand relevant
cellular processes and their molecular control (Gore et al., 2016;
Hogan and Schulte-Merker, 2017). Following the initial assembly
and lumen formation of the dorsal aorta (DA) and posterior cardinal
vein (PCV), the intersegmental vessels (ISV) form by sprouting.
This first wave of sprouting emerges from the DA at 22 h post
fertilization (hpf ), with bilateral sprouts along the somite
boundaries forming the first vascular loops (Isogai et al., 2003;
Kohli et al., 2013). A second wave of sprouting emerges at 34 hpf
and consists of venous and lymphatic sprouts (Koltowska et al.,
2015; Nicenboim et al., 2015; Yaniv et al., 2006). The venous
sprouts remodel half of the ISVs into veins (Geudens et al., 2010;
Yaniv et al., 2006). The lymphatic precursor cells are marked by the
transcription factor Prox1 in the PCV, before a cell division that
results in a differential Prox1 distribution in the daughter cells,
influencing their specification and behaviour. Cells retaining high
Prox1 levels contribute to sprouts that will form parachordal
lymphangioblasts (PLs) at the midline. The PLs subsequently
migrate and branch to shape the mature lymphatic system of the
zebrafish trunk including the thoracic duct (TD) and the dorsal
longitudinal lymphatic vessel (DLLV) (Küchler et al., 2006; Yaniv
et al., 2006). Although primary and secondary sprouts appear
morphologically similar (Isogai et al., 2003), with acto-myosin
cellular protrusions, they are driven by distinct growth factors and
downstream signalling cascades. In particular, arterial sprouting
involves Vegfa, Kdr and Plcγ, whereas venous/lymphatic sprouting
is controlled by Vegfc, Flt4, Ccbe, Adamts3 and Adamts14 (Hogan
and Schulte-Merker, 2017; Wang et al., 2020).
Recent reports have highlighted the importance of actin dynamics
in EC during morphogenesis (Gebala et al., 2016; Lamalice et al.,
2007; Phng et al., 2015). However microtubules, although crucially
involved in cell division (Belmont et al., 1990), polarity (Siegrist and
Doe, 2007) and vesicle transport mechanisms (Vale, 2003), have
received little attention in vascular biology research. This is despite
their relevance for tumour angiogenesis and vessel maintenance, as
microtubule-targeting drugs used for cancer therapy are anti-
angiogenic and/or stimulate the collapse of tumour vasculature
(Hayot et al., 2002; Kruczynski et al., 2006; Schwartz, 2009; Shi et al.,
2016; Tozer et al., 2002). The mechanisms behind the selectivity of
this phenomenon are not understood. Microtubules are unbranched
cytoskeleton polymers made of α- and β-tubulin heterodimers that
assemble in a directional manner to shape a polarised hollow tube. α-
Tubulin carries a tyrosine residue that can be removed post-
translationally by the carboxypeptidase Vasohibin 1 (Vash1)
(Aillaud et al., 2017; Nieuwenhuis et al., 2017), in a reaction
referred to as tubulin detyrosination. Tubulin detyrosination is crucial
for neuronal development (Erck et al., 2005), cell division (Barisic
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et al., 2015; Liao et al., 2019) and influences vesicle transport (Dunn
et al., 2008). Interestingly, VASH1 was previously identified as a
VEGFA-inducible gene in vitro (Abe and Sato, 2001) and is
expressed in the developing endothelium in vivo (Hosaka et al., 2009;
Shibuya et al., 2006; Watanabe et al., 2004). Viral overexpression as
well as VASH1 protein administration experiments in vitro and in vivo
show that VASH1 inhibits angiogenesis and reduces vessel diameter
(Hosaka et al., 2009; Kern et al., 2009). Conversely, Vash1 knockout
mice exhibited more vascularised tumours (Hosaka et al., 2009) and
increased angiogenesis in the ear skin injury model (Kimura et al.,
2009).
Although these studies demonstrated that VASH1 is necessary for
controlling angiogenesis in a tumour and injury onset in vivo, they
predated the discovery of VASH1 as a microtubule-modifying
enzyme. Thus, the role of microtubule detyrosination andVASH1 in
particular in the context of in vivo angiogenesis remains unknown.
Here, we use the zebrafish trunk vasculature to characterise
microtubule detyrosination and the effects of vash1 knockdown
(KD) on secondary sprouting and lymphatic development. Using
high-resolution live imaging, combined with immunofluorescence
and gene expression analysis, we find that endothelial tubulin is
predominantly detyrosinated in secondary sprouts. vash1 KD causes
morphogenic defects in secondary but not primary sprouts, impeding
proper lymphatic development. Mechanistically, vash1 loss-of-
function leads to increased EC division within secondary sprouts
associated with signs of ectopic lymphatic progenitor specification
and ultimately defective lymphatic network formation. We propose
that Vash1-controlled endothelial tubulin detyrosination supports
differential endothelial specification during cell division and sprout
elongation to achieve venous and lymphatic vessel formation in the
zebrafish trunk.
RESULTS
vash1 is highly expressed in zebrafish EC in vivo
To study the role of Vash1-driven microtubule detyrosination in
angiogenesis in zebrafish, we first investigated the conservation of
zebrafish and human variants of Vash1 (Fig. 1A,B) with CLUSTAL
O (Uniprot). The analysis predicted 65.24% similarity between
zebrafish and human Vash1 (Fig. 1A), including the previously
identified residues necessary for tubulin tyrosine and glutamate
recognition, and the catalytic active site Cys-His-Ser triad
(Adamopoulos et al., 2019; Nieuwenhuis et al., 2017; Sanchez-
Pulido and Ponting, 2016) (Fig. 1B). RT-qPCR on RNA extracted
from EC sorted from Tg[fli1a:nEGFP]y7 embryos at 24 and 48 hpf
showed dynamic expression of vash1 during zebrafish
development. During the sprouting phase (24 hpf), vash1
expression was 5-7 times higher in EC than in non-EC,
decreasing at 48 hpf (Fig. 1C,D). Although these differences were
not statistically significant, they were independently confirmed with
a second primer set. In addition, in situ hybridization on fixed wild-
type embryos at 24, 34 and 48 hpf showed a variable expression of
vash1 in the trunk (Fig. 1E-G). vash1 mRNA expression is
detectable in the DA and other peri-vascular tissues in the trunk at
24 and 34 hpf (Fig. 1E,F), but not at 48 hpf (Fig. 1G).
In summary, vash1 is expressed in the zebrafish endothelium and
the amino acids responsible for the carboxypeptidase function are
conserved in zebrafish.
Vash1 carboxypeptidase function is conserved in zebrafish
A splice-site interfering morpholino (MO) targeting the intron3-
exon4 boundary of nascent vash1 RNA (Fig. 2A) efficiently
decreased the expression of Vash1 in zebrafish embryos (Fig. 2B).
Injections of MO against vash1 and control MO were performed in
the Tg[fli1ep:EGFP-DCX] zebrafish line, selectively labelling
endothelial microtubules by expression of GFP-tagged
microtubule-binding protein doublecortin (Phng et al., 2015).
Tubulin detyrosination was assessed by antibody staining against
the glutamate residue of α-tubulin that becomes available after the
tyrosine residue is removed by Vash1 (Fig. 2C). Microtubules
detected by this antibody are referred to as microtubules with
detyrosinated tubulin (dTyr). Whereas control embryos exhibited a
high intensity array of dTyr in the neural tube, centrosomes,
motoneurons (Fig. 2D,E) and EC (Fig. 2E′, arrowhead), vash1 KD
embryos showed strongly diminished labelling of these structures
(Fig. 2F,G). In particular, endothelial labelling was absent following
vash1KD (Fig. 2G′). Quantification of the ratio between dTyr tubulin
and DCX (endothelial microtubules) signal intensities (Fig. 2H)
confirmed that detyrosination of endothelial microtubules is
significantly reduced in vash1 KD ISVs (dTyr/DCX=0.23±0.15;
mean±s.d.) in comparisonwith control ISVs (dTyr/DCX=0.32±0.24).
Thus, Vash1 detyrosinates tubulin in zebrafish tissues including the
endothelium.
Vash1 regulates secondary sprouting
Live-imaging of sprouting angiogenesis in Tg[kdrl-l:ras-Cherry;
fli1a:nEGFP] embryos showed comparable primary sprouting and
ISV network formation in control and vash1KDembryos (Fig. 3A-F).
However, secondary sprouting progressed abnormally in vash1 KD
embryos. In control conditions, each secondary sprout finds its ISV,
with very few occurrences of two secondary sprouts reaching to the
same ISV. Secondary sprouts of vash1KD embryos exhibit persistent
protrusions, reaching two different ISVs in 13.8% of the cases, in
comparison with 2.4% in the controls (Fig. 3G). In search of the
underlying mechanism, we asked whether there were more secondary
sprouts emerging from the PCV. Quantification revealed a slightly
higher number of secondary sprouts in vash1 KD embryos, but
without statistical significance (Fig. 3H). Furthermore, the transient
three-way connections (schematic in Fig. 3I) that regularly form
during vein/lymphatic development (Geudens et al., 2019) took
longer on average to resolve (12.4±1.3 h in vash1 KD in comparison
with 8.9±1 h in the control). In addition, in vash1 KD embryos, 46%
of the three-way connections take longer to resolve than the average, in
comparison with 26% of the controls (Fig. 3J), showing a higher
variance in the morphants. We hypothesize that there is a disturbed
cell migration mechanism, or a surplus of cells in these structures that
do not allow for it to resolve as fast. Together, these results suggest that
vash1 regulates secondary sprouting and three-way connection
resolution.
Vash1 regulates cell proliferation
As the temporary three-way connection resolves by polarized EC
migration (Geudens et al., 2019), we hypothesized that disturbed
cell migration or a surplus of cells in these structures are causative
for its prolonged persistence. Quantification revealed that the vash1
KD secondary sprouts of Tg[kdrl-l:ras-Cherry, fli1a:nEGFP]
embryos exhibited an increased number of EC (Fig. 4A,C)
compared with control secondary sprouts (Fig. 4B,C). The vast
majority (76%) of secondary sprouts of control embryos exhibit one
nucleus per sprout, the remaining (24%) have a maximum of two
nuclei per sprout. In contrast, only 48% of vash1 KD sprouts
exhibited one nucleus per sprout. The majority (52%) of vash1 KD
sprouts had two to four nuclei. To uncover whether these defects are
due to increased cell division we have quantified cell divisions from
movies acquired between 30 and 70 hpf at 15 min time resolution
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Fig. 1. See next page for legend.
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and observed twice as many nuclear divisions in the vash1 KD
secondary sprouts than in controls (Fig. 4D; Movies 1 and 2). This
difference in proliferation was not detected in EC of the ISVs
(Fig. S2A), suggesting that Vash1 negatively regulates cell division
during secondary sprouting.
The lymphatic progenitor cells are derived by bi-potential
precursors that divide during secondary sprouting into two
daughter cells with different prospective identities: venous and
lymphatic. As we observe increased secondary sprout cell divisions,
we hypothesized that this could impact on the specification of
lymphatic EC. To assess the role of Vash1 in this process we
performed Prox1 immunostaining in vash1 morphants at 36 hpf,
during sprouting. We observed higher frequencies of Prox1-
positive cells in the PCV in vash1KDwhen compared with control
MO injected siblings. This suggests that either Prox1 is ectopically
induced in PCV or Prox1 expression is retained in both daughter
cells after the bi-potential precursor cell division. Quantification of
the Prox1-positive nearest neighbour revealed that the Prox1-
positive cells in the PCV are always within close proximity of the
venous sprout in vash1 KD embryos, but not in the control MO
injected siblings (Fig. 4E-G). These results suggest that Vash1
plays a role in lymphatic progenitor cell specification, potentially
by controlling Prox1 distribution in daughter cells post cell
division.
Endothelial microtubules are selectively detyrosinated in
secondary sprouts
Immunostaining against dTyr in fixed uninjected Tg[fli1ep:EGFP-
DCX] embryos at 24 and 34 hpf (Fig. 5A-F) revealed that, although
the microtubules of the primary sprouts showed little to no staining
(Fig. 5B,C,C′), the microtubules of the vast majority of secondary
sprout cells were strongly labelled (Fig. 5E,F,F′). Quantification of
fluorescence signal in endothelial microtubules from secondary
sprouts was challenging owing to the overlap of EC from the
primary sprouts. To mitigate this, we used zebrafish plcγ (plcg1)
morphants, which exhibit no primary sprouting and subsequent
arterial ISV formation as the VEGFR2-Plcγ-signalling pathway is
selectively required for primary spouting (Hogan et al., 2009a).
Secondary sprouting, however, proceeds in these embryos, and the
absence of ISVs facilitates the measurement of signal intensities in
secondary sprouts (Fig. 5G-I). Quantification of the signal intensity
ratio between dTyr and DCX confirmed a threefold higher signal in
secondary sprouts of plcγ morphants than in primary sprouts of
control morphants (Fig. 5J). In summary, detyrosinated
microtubules appear particularly abundant in secondary sprouts,
in comparison with primary sprouts or established ISVs.
Vash1 regulates formation of trunk lymphatic vasculature
Closer examination of Tg[fli1a:EGFPy1,kdr-l:ras-Cherry]
embryos further revealed defects in the formation of lymphatic
structures. At 52 hpf, the number of PLs emerging as lymphatic
progenitors at the horizontal myoseptum was dramatically reduced
in vash1 KD (24%±27) compared with control embryos (83%±22)
(Fig. 6A-C). PLs formation was partially rescued by co-injection
with vash1mRNA (Fig. 6C), indicating that the observed lymphatic
defects are indeed caused by loss of Vash1 function. Defective PL
formation was further confirmed by two additional Vash1 MOs
(Fig. S3A-E).
In addition, PLs in vash1 morphants frequently appeared
connected to the venous ISVs, unlike in sibling controls
(Fig. 6D). Occasionally at 52 hpf, and later in development at
4 dpf, we observed kdrl-mCherry-positive lumenised connections
between ISVs, formed at the horizontal myoseptum (Fig. 6B,F,F′,
arrowhead), suggesting they are aberrant vascular shunts. To assess
perfusion of the aberrant ISV-to-ISV connections, we injected
Tg[fli1a:EGFP]y1 embryos with fluorescent beads into the general
circulation (Qtracker 705 quantum dots) at 4 dpf (Fig. S4B-D) and
found that two-thirds of the connections (n=10/15) are lumenized,
specifically the ones at the horizontal myoseptum.
PLs are transient structures that normally form by sprouting of a
subset of the secondary sprouts (Hogan et al., 2009a; Koltowska
et al., 2015; Yaniv et al., 2006). From their initial position at the
horizontal myoseptum, they migrate ventrally to shape the main
trunk lymphatic vessel, the TD (Bussmann et al., 2010). The TD can
be detected in Tg[fli1a:EGFP,kdr-l:ras-Cherry] embryos as an
eGFP-positive and mCherry-negative vessel that locates between
the DA and the PCV at 4 dpf (Fig. 6E). Control embryos showed
almost complete TD formation along the trunk, whereas in vash1
morphants the TD was mostly absent (Fig. 6E′,F″). Quantification
revealed a significant reduction in the percentage of somites with a
TD fragment in vash1 KD embryos (20%±4.18) compared with
controls (78%±4.4) (Fig. 6G). In addition, at this developmental
stage, we observed a variable degree of under-development of the
intestinal vascular system in the vash1 morphants (Fig. S6A-I).
For further validation of the vash1 morphant phenotypes, we
generated F0 CRISPRmutants (CRISPants) with a dgRNA targeting
exon 4 of vash1 at which two codons translate into lysine (K) and
cysteine (C) at positions 174 and 175 of Vash1 (Fig. 6H). These
amino acids are crucial for the carboxypeptidase function of Vash1
(Adamopoulos et al., 2019; Nieuwenhuis et al., 2017) (Fig. 1B).
Imaging 60 injected embryos revealed decreased PL formation in the
trunk of 14 embryos (Fig. 6I). Sequencing of the targeted exon-4 of
the vash1 locus in these 14 embryos revealed mutations (specified in
Fig. S5A) affecting either both lysine 174 and cysteine 175, or only
cysteine 175 in all CRISPants, but not control-injected embryos.
Given the essential function of these residues, the results suggest that
the mutant Vash1 in CRISPants cannot detyrosinate microtubules. In
contrast, embryos injected with control gRNA and Cas9 exhibited
regular PL coverage and no mutations. Together, these results
indicate that the reduction of the PL coverage is a result of a lack of
tubulin detyrosination as a consequence of either vash1 KD in
morphants or mutation in vash1 CRISPants, respectively. In
summary, vash1 zebrafish morphants and mutants show a decrease
in lymphatic progenitors and, as a consequence, a decrease in mature
lymphatic vasculature of the trunk.
DISCUSSION
Tubulin detyrosination is important for several differentiation
events and developmental processes, such as myogenesis (Chang
Fig. 1. vash1 is highly expressed in zebrafish endothelium. (A,B) Amino
acid sequence alignment using CLUSTALO (Uniprot) of human and zebrafish
Vash1 showing 65.24% sequence similarity (A), including in the indicated
residues necessary for tubulin detyrosination (B). (C,D) Analysis of vash1
expression in zebrafish embryos at 24 and 48 hpf. FACS sorting and gating
strategy for isolation of nEGFP+ and nEGFP− cells from Tg[fli1a:nEGFP]y7
embryos, their RNA extraction and reverse transcription leading to qPCR (C).
vash1 expression, analysed by two independent primer pairs, shows a
tendency towards being enriched in the endothelium of zebrafish embryos at
24 hpf (D). Data normalised to housekeeping genes. Data are mean±s.d. Each
data point is an average of three technical replicates per sample, and each
experiment has three biological replicates per developmental stage. n.s., not
significantly different (Mann–Whitney test). (E-G) In situ hybridization of vash1
in the zebrafish embryo trunk at 24 hpf (E), 34 hpf (F) and 48 hpf (G).
Arrowhead indicates where the dorsal aorta (DA) locates in the embryos.
Pictures are representative of three replicated experiments. n=40 embryos for
each developmental stage.
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et al., 2002; Gundersen et al., 1989; Kerr et al., 2015) and
neurogenesis (Aillaud et al., 2017; Erck et al., 2005), although the
cellular mechanisms behind this remain poorly understood. Vash1
was recently identified as the catalyst of this reaction (Aillaud et al.,
2017; Nieuwenhuis et al., 2017). Vash1 is also anti-angiogenic. The
cellular mechanisms behind the vascular phenotypes that are caused
by Vash1 loss- and gain-of-function are not well understood.
In this study, we identified Vash1 as a novel regulator of EC
sprouting from the PCV and the subsequent formation of lymphatic
vessels in the zebrafish trunk. We showed that microtubules in
secondary sprouts are particular in that they are highly detyrosinated
by Vash1 (Fig. 7A-C). We further show that Vash1 is dynamically
expressed in the zebrafish in the endothelium of the DA and in
perivascular tissues during both sprouting waves. This is in
accordance with earlier reports of Vash1 being highly expressed
in angiogenic vessels, healthy or tumour associated, in vitro and in
vivo (Watanabe et al., 2004) as well as in arteries (Shibuya et al.,
2006). Previous research also showed that, despite its induction by
VEGF, Vash1 is mostly expressed in the quiescent endothelium,
adjacent to the sprouting front (Kimura et al., 2009), potentially to
control the amount of sprouting cells.
Our present study in the zebrafish demonstrated that depletion of
Vash1 reduces the level of microtubule detyrosination and
negatively affects secondary sprouting (Fig. 7D,E). Sprouts
emerging from the PCV in vash1 morphants contain more
endothelial nuclei, as EC divide almost twice as often as in
Fig. 2. Endothelial microtubules are
detyrosinated by Vash1 in zebrafish.
(A,B) Knockdown (KD) strategy using a
morpholino (MO) targeting the intron3-exon4
(I3-E4) (A) efficiently decreases Vash1
protein levels as detected by western blot
(B). 48 hpf embryo lysate was used, three
replicates were performed. (C) Mechanism
of tyrosine cleavage from α-tubulin carboxy-
terminus by Vash1, resulting in
detyrosinated tubulin (dTyr). Detyrosination
exposes a glutamate residue accessible by a
custom-made antibody (Liao et al., 2019).
(D-G′) Immunostainings of 48 hpf Tg[fli1ep:
EGFP-DCX] embryos detect detyrosinated
microtubules (referred to as dTyr; D-G) and
GFP-labelled microtubules (referred as
DCX; D,F). G and G′ show immunostaining
of dTyr upon vash1 KD, compared with the
control MO injected sibling embryos (E,E′).
Arrows (E,G) indicate neural tube, with
typically detyrosinated microtubules (E),
reduced upon vash1 KD (G). Arrowheads
indicate endothelial detyrosinated
microtubules, only present in control
embryos (E,E′). Asterisks (E,G) indicate
motoneurons exhibiting
high dTyr signal in control embryos
(E,E′) and decreased dTyr signal in
vash1 KD embryos (G,G′). Pictures are
representative of three biological replicates.
(H) Quantification of ratios between dTyr and
DCX intensity signals of each ISV in control
and vash1 KD groups. AU, arbitrary units.
Each data point is one ISV, n=155 ISVs from
15 embryos (control) and n=205 ISVs from
12 embryos (vash1 KD), from three
replicates. Data are mean±s.d. ***P<0.0002
(Mann–Whitney test). Pictures are
representative of three replicated
experiments.
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control conditions. Furthermore, aberrant protrusions from these
sprouts reach neighbouring ISVs almost six times more often than in
controls. These results suggest that Vash1-driven microtubule
detyrosination limits excessive venous EC sprouting behaviour and
proliferation during lymphovenous development in zebrafish
(Fig. 7F). However, given that Vash1 may also have additional
functions beyond its carboxypeptidase activity driving tubulin
detyrosination, the KD results alone do not demonstrate causality.
The fact that we observe a similar defect in PL formation in F0
CRISPants carrying mutations that disrupt its catalytic function,
however, strongly suggests that microtubule detyrosination is
indeed the mechanism required for adequate lymphovenous
patterning. Nevertheless, future work will need to clarify exactly
how microtubule detyrosination controls secondary sprouting and
lymphatic specification.
Although the cellular mechanisms of primary and secondary
sprouting in zebrafish appear to be very similar (Isogai et al., 2003),
secondary sprouting uses alternative signalling pathways and entails
a unique specification step that establishes both venous ISVs and
lymphatic structures. Secondary sprouting in zebrafish is triggered
by Vegfc and activation of its receptor Flt4 in a subpopulation of EC
in the PCV (Bussmann et al., 2010; Hogan et al., 2009b) that
Fig. 3. Vash1 deficient embryos exhibit aberrant secondary sprouting. (A-F) Primary and secondary sprouting in control and vash1 KD Tg[kdr-l:ras-
Cherry]s916 zebrafish embryos, with labelled blood vessels. Primary sprouting occurs from the DA at 24-30 hpf (A-C). Secondary sprouting occurs from the
PCV at 34-40 hpf and ISVs form (D-F). Red arrowheads indicate secondary sprouts (E,F). Pictures are representative of three replicated experiments.
(G,H) Quantification of observed frequency that either one or two different sprouts reach an ISV (G) and of number of secondary sprouts per six somites (H).
n=87 ISVs from 20 embryos for vash1 KD group, and n=82 ISVs from 23 control embryos, from three biological replicates. **P<0.0021 (Mann–Whitney test). n.s.,
non-significant. (I,J) A transient three-way connection is formed when the secondary sprout connects with the primary ISV and lumenizes (I), after which one of its
branches is resolved. The duration of three-way connections from lumenization to resolution was quantified in control and vash1 MO-injected embryos (J).
Data points represent 45 ISVs from 34 embryos for vash1 KD and 39 ISVs from 30 embryos for control groups, from four biological replicates. **P<0.0021
(Kolmogorov–Smirnov test). Data are median±s.d. (G) and mean±s.d. (H,J).
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increase prox1a expression before a cell division (Koltowska et al.,
2015; Nicenboim et al., 2015). This cell division is thought to lead
to distinct identity acquisition by the daughter cells, as one Prox1-
negative cell remains in the PCV while the other Prox1-positive cell
sprouts from the PCV to ultimately become a lymphatic progenitor
(Koltowska et al., 2015; Nicenboim et al., 2015). The specification
of lymphatic progenitors is influenced by the levels of prox1a
expression, with high prox1a expression thought to favour
lymphatic specification (Koltowska et al., 2015). In vash1
morphants, the observed increase of neighbouring cells with
prox1a expression suggests a retention of the Prox1 protein in
both daughter cells upon cell division. This highly aberrant
phenotype is reminiscent of what has been published for embryos
with vegfc overexpression (Koltowska et al., 2015), suggesting that
the differential activity of the Vegfc-Flt4 signalling axis is possibly
perturbed upon vash1 KD. In the case of vegfc overexpression, this
is consistent with a disruption of prox1a in the daughter cells,
increase of cell divisions and disruption of the asymmetric cell
behaviour of the daughter cells.
Intriguingly, microtubule detyrosination has been shown to
influence mitotic and meiotic spindle (Akera et al., 2017; Barisic
et al., 2015; Liao et al., 2019), with emerging evidence for a
potential role in asymmetric cell fate (Akera et al., 2017; Laloraya,
2018). Given recent discoveries of asymmetric cell fate acquisitions
and behaviour upon cell division in EC (Costa et al., 2016; Koltowska
et al., 2015; Nicenboim et al., 2015), it is tempting to speculate that the
lack of detyrosinated microtubules interferes with this process during
initiation and progression of secondary sprouting, such that
endothelial daughter cells retain their undifferentiated state and fail
to specialise into lymphatic EC. Failure to differentiate under activated
conditions is frequently associated with continued proliferation, also
in EC (Benedito et al., 2008; Siekmann and Lawson, 2007). A recent
study reported a similar increase in secondary sprout numbers in the
nova2 zebrafish mutants (Baek et al., 2019). Nova2 acts as a splicing
factor that limits Vegfc/Flt4 signalling. Its absence causes premature
and excessive formation of sprouting venous EC that fail to fully
differentiate into functional lymphatic structures owing to an
increase of Vegfc/Flt4/Mapk signalling and consequently persistent
proliferation.
According to current understanding, the decisive fate-
determining step in the formation of the lymphatic system in the
zebrafish trunk is the acquisition of a prox1a high expression status
in a few cells of the PCV. These cells emerge from the PCV as
secondary sprouts to form first the PLs and subsequently expand to
form the TD and other trunk lymphatic vessels (Koltowska et al.,
2015; Nicenboim et al., 2015). Recent work demonstrated that a
Fig. 4. Secondary sprouts in vash1 morphants exhibit more Prox1+ cells and higher proliferation rates. (A,B) Secondary sprouts in Tg[kdr-l:ras-
Cherrys916,fli1a:nEGFPy7] embryos, with membrane- and nuclei-labelled endothelial cells (EC) in control (A) and vash1 KD embryos (B). White
arrowheads indicate nuclei in secondary sprouts (outlined by dashed line). (C,D) Quantification of the number of endothelial nEGFP-labelled nuclei in
secondary sprouts immediately before connection to the ISV (C), and cell division frequency in the secondary sprout before and after connecting to the ISV,
from 30 to 70 hpf (D). Quantifications are from three biological replicates. **P<0.0021, ****P<0.0002 (Mann–Whitney test in C, t-test in D). (E,F) Prox1-positive
(Prox1+ve) EC were identified by immunostaining in Tg[fli1a:nEGFPy7] embryos in control and vash1 morphants. In controls, migrating cells in secondary
sprouts are Prox1+ve and their neighbouring EC in the PCVare Prox1-negative (E). In vash1morphants, both EC in the secondary sprout and the neighbouring
EC still in the PCV are Prox1+ve (F). Analysed EC are highlighted (dashed line), and neighbouring EC are connected with a line. (G) Quantification of incidence
of nEGFP+ Prox1+ve neighbouring EC per seven somites per embryo in both control and vash1 MO-injected embryos. **P<0.0021 (Mann–Whitney test).
Pictures are representative of three replicated experiments.
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secondary sprout either contributes to remodelling a pre-existing
ISV into a vein, or forms a PL. In addition, a single secondary sprout
is able to simultaneously form a venous ISV and give rise to
lymphatic progenitors, which can be seen emerging from a
remodelled venous ISV (Geudens et al., 2019; Isogai et al.,
2003). Unlike in control siblings, the few PLs forming in vash1
morphants are found associated with venous ISVs and often have a
more vascular appearance, suggesting a defect in lymphatic
specification. In addition, the number of PLs present appears to
be insufficient to form the trunk lymphatic vasculature. The
expressivity of this morphant phenotype is variable, suggesting that
the formation of PLs and lymphatics may be dynamically regulated
and affected by variations in KD efficiency and thus Vash1 levels.
Interestingly, homozygous and heterozygous Vash1 mouse mutants
show differences in their vascular phenotype upon injury (Kimura
et al., 2009), suggesting a dose-dependent effect of Vash1.
Vash1 is highly conserved across eukaryotes, especially the
three amino acids that constitute a non-canonical Cys-His-Ser
Fig. 5. Microtubules of secondary sprouts are selectively detyrosinated. (A-I′) Immunostainings using antibody detecting the glutamate amino acid of
detyrosinated microtubules (dTyr) during primary (A-C) and secondary (D-I) sprouting in uninjected (A-F) and plcγ KD (G-I) Tg[fli1ep:EGFP-DCX]
embryos, labelling all endothelial microtubules (DCX). C′,F′ and I′ are magnifications from boxed region in C,F,I, respectively. plcγ KD embryos (G-I′) show
reduced primary sprouting, facilitating the visualization and quantification of dTyr signal specifically in secondary sprouts. Arrowheads indicate secondary sprouts.
(J) Quantification of the dTyr/DCX signal intensities in primary sprouts of control MO-injected embryos, and secondary sprouts from plcγ MO-injected embryos.
n=52 control primary sprouts from 18 embryos, n=24 plcγ KD secondary sprouts from 12 embryos, from one experiment. ****<0.00001 (Mann–Whitney test).
Pictures are representative of 3 replicated experiments.
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catalytic triad active site (Sanchez-Pulido and Ponting, 2016) that
are necessary for the tubulin detyrosination function
(Adamopoulos et al., 2019; Nieuwenhuis et al., 2017). Human
and murine VASH1 protein variants induce similar effects in
angiogenesis assays when applied ectopically (Watanabe et al.,
2004), suggesting similar functions across these species. Our
pairwise sequence analysis indicates that the residues necessary
for tubulin recognition and detyrosination (Adamopoulos et al.,
2019; Nieuwenhuis et al., 2017) are conserved between human
and zebrafish versions of Vash1, suggesting conserved
carboxypeptidase function. The fact that we could observe
absence of microtubule detyrosination in zebrafish upon vash1
KD further supports this hypothesis.
Although earlier studies using gain-of-function approaches
reported anti-lymphangiogenic activities of ectopically added
VASH1 in the mouse cornea and in tumour conditions (Heishi
et al., 2010), our loss-of-function analysis in zebrafish suggests a
selective pro-lymphangiogenic function of Vash1 by supporting
lymphovenous specification. Although this appears to be
contradictory at first sight, a possible influence on Vegfc-
mediated effects may explain the discrepancy. The ectopic
VASH1 might act as an acute inhibitor of Vegfc signalling in
Fig. 6. Vash1 regulates formation of trunk lymphatic vasculature. (A,B) Tg[fli1a:EGFP]y1 labels parachordal lymphangioblasts (PL, indicated by asterisks)
of control (A) and vash1 KD embryos (B) at 52 hpf. (C) Quantification of the percentage of somites with PLs in embryos injected with control and vash1 MO,
as well as the rescue with 150 pg vash1 mRNA. Each point corresponds to one embryo. (D) Quantification of percentage of PLs connected to a venous ISV in
embryos injected with control and vash1 MO; 6-8 somites. In C, n=62 for controls, n=62 for vash1 morphants and n=59 for vash1 morpholino and RNA-injected
embryos. In D, n=25 for controls and n=23 for vash1morphants. Three biological replicates were carried out. *P<0.0332, **P<0.02, ****P<0.0001 (Kruskal–Wallis
in C, Mann–Whitney test in D). (E-G) Zebrafish trunk of 4 dpf Tg[kdr-l:ras-Cherrys916,fli1a:EGFPy1] zebrafish embryos. Arrowheads indicate GFP- and mCherry-
positive putative ISV-to-ISV connections in vash1 KD embryos (F, ISV-to-ISV connection in F′). The main axial lymphatic in the zebrafish trunk – the thoracic duct
(TD) – is GFP-positive, mCherry-negative (E,E′, arrow), and absent in the vash1 KD embryo (F, ISV-to-ISV connection in F″). The percentage of somites with TD
was quantified (G). n=60 control and n=63 morphants analysed. ****P<0.0001 (Mann–Whitney test). (H) Strategy for CRISPR mutation of exon 4 of vash1
includes design of a duplex guide RNA (dgRNA) to target the codons that translate into lysine and cystein (in bold) of positions 174 and 175 of the zebrafish Vash1
protein, crucial for the carboxypeptidase function. (I,J) Trunk region of Crispr/Cas injected vash1 knockout (KO) Tg[fli1a:EGFP]y1 embryos (J) in comparison with
the control (I). Embryos injected with control gRNA and Cas9 exhibit regular PL coverage (I, asterisks) and no mutation. vash1 CRISPants – embryos with
confirmed CRISPR mutations – lack PLs (J). n=30 control embryos, n=14 CRISPants.
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existing lymphatic structures such as cornea or tumour, thus
inhibiting further lymphatic growth, whereas the absence of Vash1
during secondary sprouting resembles excessive Vegfc signalling
and interferes with lymphatic differentiation. Future work will need
to establish whether and how Vash1-mediated detyrosination of
endothelial microtubules restricts excessive Vegfc signalling, in
some or all daughter cells, during formation of secondary sprouts
from the PCV.
In conclusion, our work identifies Vash1 as a conserved tubulin
carboxypeptidase in zebrafish, with a selective role in secondary
sprouting and lymphatic cell formation. We propose that a balance
of the number of EC sprouting from the cardinal vein is maintained
by Vash1 via microtubule detyrosination and consequent EC
divisions and that Vash1 has a role in lymphatic specification and
formation in the zebrafish trunk.
MATERIALS AND METHODS
Zebrafish maintenance and transgenic lines
Zebrafish (Danio rerio) were raised and staged as previously described
(Kimmel et al., 1995). For growing and breeding of transgenic lines, we
complied with regulations of the animal ethics committees at the Max
Delbrück Center for Molecular Medicine, Berlin (Aleström et al., 2019).
The following transgenic lines were used: Tg[fli1a:EGFP]y1 (Lawson and
Weinstein, 2002) labels all EC, Tg[fli1a:nEGFP]y7 labels all EC nuclei
(Roman et al., 2002), Tg[kdr-l:ras-Cherry]s916 (Hogan et al., 2009a) labels
EC membrane and Tg[fli1ep:EGFP-DCX] (Phng et al., 2015) labels
endothelial doublecortin, a microtubule-associated protein.
dTyr immunofluorescence staining and imaging
Embryos were treated with 1-phenyl-2-thiourea (PTU) at stages later than
24 hpf to prevent pigment formation. Embryos were fixed with 4%
paraformaldehyde (PFA) for 10 h at 4°C, and kept for a maximum of 4 days
in phosphate-buffered saline (PBS) with 0.5% Triton X-100 (PBTX) at 4°C.
Embryos were permeabilized by dehydrating them in a methanol series –
25%, 50% and 75% –and incubated for 1 h at −20°C, before being
rehydrated in a descending methanol series – 75%, 50% and 25% – and
washed three times with PBTX and post-fixed with 4% PFA for 10 min. The
embryos were incubated for 2 h in blocking buffer (10% horse heat
inactivated serum, 1%DMSO, 100 mMmaleic acid in 0.1% PBTX) at room
temperature. Embryos were incubated at 4°C overnight with primary
antibodies (indicated below) diluted in blocking buffer. The embryos were
then washed with a solution containing 1%DMSO and 100 mMmaleic acid
in 0.1% PBTX at room temperature and blocked again for 30 min before
being incubated with secondary antibodies diluted in blocking buffer
overnight. Embryos were washed again in 1% DMSO and 100 mM maleic
acid in 0.1% PBTX, fixed with PFA 4% for 30 min at room temperature,
washed again and stored at 4°C in PBST until being mounted in glycerol and
stored at 4°C.
Primary antibodies used were anti-detyrosinated tubulin (1:600, rabbit;
Liao et al., 2019) and anti-GFP FITC conjugate (1:200, mouse, Abcam,
ab6662). The secondary antibody used was Alexa 568 against rabbit (1:200,
donkey, Invitrogen, A10037).
dTyr immunofluorescence quantifications
Substacks containing single ISVs were cropped manually from images
of whole Tg[fli1ep:EGFP-DCX] embryos stained with dTyr antibody.
To estimate the background, which varied locally owing to
autofluorescence of the embryos, each image was filtered with a large
Gaussian filter (radius=50 pixels) and subtracted from the original
image. A maximum intensity projection of the DCX channel was used
to manually segment endothelial microtubules, with particular care
taken to exclude the neurons. The resulting mask was applied to
background corrected, sum intensity projections of DCX and dTyr
channels. Mean intensity was extracted and plotted to quantify the
normalised and direct differences of tubulin detyrosination intensity in
different experimental groups. The analysis was performed in Fiji. For
all quantifications a minimum of three biological replicates was carried
out per quantification.
Prox1 immunofluorescence staining, imaging and quantification
Whole-mount Prox1 immunofluorescence was performed as previously
described (Koltowska et al., 2015; Shin et al., 2017) in Tg[fli1a:
nEGFP]y7. Antibodies used were chicken α-GFP (1:400, Abcam,
ab13970) rabbit α-Prox1 (1:500, AngioBio Co, 11-002P), α-rabbit
IgG-HRP (1:1000, Cell Signaling Technology, BioNordika, 7076S)
Fig. 7. Model of Vash1 function in zebrafish trunk. (A-F) Microtubule detyrosination is catalysed by Vash1 (A), particularly occurring in secondary sprouts (B).
In the secondary sprouts, Vash1-mediated detyrosinatedmicrotubules keep control of the number of sprouting cells, cell proliferation and cell protrusion formation
to avoid over-sprouting (C). Secondary sprouts with correctly detyrosinated microtubules form PLs at 2 dpf, which in turn form the TD at 3-4 dpf (C). Upon vash1
KD, microtubules of secondary sprouts are no longer detyrosinated (D,E). Cells of secondary sprouts over-proliferate, fail to form PLs and a functional TD,
although PLs forming from veins still occur (F).
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and TSA-Cy3 (1:50, PerkinElmer, Akoya, NEL744001KT). The trunks
of zebrafish were cut at the junction of the yolk and the yolk extension
and flat mounted in clearing solution Omnipaque™ (350 mg I/ml
iohexol, GE Healthcare) on a glass-bottom imaging dish. The images
were taken with the inverted confocal Leica SP8 DSL system using a
25× water objective.
Prox1 and nEGFP double-positive cells were identified in the PCV and
secondary sprouts. Neighbouring cells were defined by adjacent nEGFP+
EC, normally corresponding to a cell in the PCV and the other in the
secondary sprout. When two neighbouring EC expressed Prox1, the
occurrencewas quantified. The number of incidences was counted per seven
somites in every embryo, in three biological replicates.
In situ hybridization
Primers used to amplify templates for riboprobe production were designed
to span the exon/exon junction: GAGACCTGCCCAAGATTCCAG and
GGCCGCTTCTCTACTGATGG. The anti-sense transcript was transcribed
in vitro using 20 U/μl T7 polymerase (Promega). The transcription was
carried out with 5× transcription buffer (Promega, P118B), DTT 0.1 M
(Promega, P1171), digoxigenin labelling mixes (Roche) and 40 U/μl
RNAsein (Promega) for 2 h at 37°C. The plasmid was removed by adding
2 μl of RNase-free DNase I and 18 μl sterile water, mixed and incubated for
30 min at 37°C. The RNA product, the riboprobe, was purified using the
RNA easy kit (Qiagen) and diluted to 1 ng/μl in Hyb+ buffer (Thisse and
Thisse, 2008).
The in situ hybridizations were performed as previously described (Thisse
and Thisse, 2008; Habeck et al., 2002), with treatments at the following
concentrations of proteinase K in PBST (PBS, 0.1% Tween-20): at 24 hpf,
0.01 mg/ml, incubated for 5 min; at 34 hpf, 0.01 mg/ml, incubated for 8 min;
at 48 hpf, 0.02 mg/μl, incubated for 30 min. The embryos were incubated in
NBT/BCIP staining solution (Roche) overnight at 4°C. The reaction was
stopped by washing with PBST three times, fixed for 20 min in PFA,
dehydrated in methanol, and mounted and imaged within a week, in glycerol.
The imaging was performed using a Zeiss Stemi CV11 stereoscope equipped
with an AxioCam and processed using the software AxioVision Rel. 4.5.
Live imaging and analysis
Embryos were dechorionated and anaesthetised with 0.014% (1×) tricaine
methanesulfonate (MS-222, Sigma-Aldrich). Embryos were then mounted
in 0.8% low melting point agarose (Life Technologies) containing 0.014%
tricaine and immersed in E3 buffer containing 0.014% tricaine and 0.003%
PTU when indicated. Live embryos were imaged using an upright 3i
Spinning Disk Confocal Microscope using Zeiss Plan-Apochromat 20× and
40×/1.0 NA water dipping objectives. Image processing was performed
using Fiji software (Schindelin et al., 2012). XY drifts were corrected using
the MultiStackReg plugin (from B. Busse, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, USA).
Secondary sprout and three-way connection parameters
The number of secondary sprouts was quantified in 15 min time-lapse
movies from 24 to 48 hpf, in Tg[kdrl-l:ras-Cherry,fli1a:nEGFP] embryos.
The number of nuclei was assessed in each secondary sprout immediately
before connection to the pre-existing ISV. Cell divisions in secondary
sprouts were quantified by adding nuclear (nEGFP) divisions from the time
of emergence, until the resolution of the three-way connection with
pre-existing ISVs. The duration of the three-way connection was quantified in
the same embryos from the moment it connected to the primary ISV and
lumenised until the three-way connection was resolved. For all quantifications
a minimum of three biological replicates was carried out per quantification.
Lymphatics: PL and TD quantifications
PL and TD were quantified by examining z-stacks of 52 hpf and 4 days post
fertilization (dpf ) Tg[fli1a:EGFPy1] embryos and counting the presence or
absence in each somite, starting from the fifth-most anterior ISV. The
number of PL associated with venous ISVs were identified by a connection
to a venous ISV at 52 hpf in vash1 morphants and control siblings. For all
quantifications a minimum of three biological replicates was carried out per
quantification, using six to eight somites per embryo.
Statistical analysis
Zebrafish embryos were selected on the following pre-established criteria:
normal morphology, beating heart and flowing blood. All morphant
embryos analysed in this project exhibited no apparent visual phenotype.
The experiments were not randomised and the investigators were not
blinded during experiment and analysis.
In order to decide whether a parametric or non-parametric test should be
used to compare different experimental groups, we assessed whether the
population was normally distributed using an Anderson-Darling test. If so,
t-test and regular ANOVA were performed, if not, Mann–Whitney and
Kruskall–Wallis tests were performed. Data are presented in all graphs as
mean±s.d., except in Fig. 3G in which they are median±s.d.
Cell isolation for gene expression analysis
Tg[fli1a:nEGFP]y7 were outcrossed and their embryos collected. Negative
embryos were also collected under the stereoscope, to serve as GFP-negative
control siblings during cell sorting. Embryos were treated with 0.003% PTU
when older than 24 hpf. The embryos were dechorionated by adding
pronase (1 mg/ml) for 15 min, washed in E3 buffer and anaesthetised using
0.16 mg/ml tricaine methanesulfonate (Sigma-Aldrich). Then 250 embryos
were transferred to a 1.5 ml tube and the yolk sac was removed by two
rounds of centrifugation (or until the solution was clear) with calcium ringer
solution at 2000 rpm (400 g) at 4°C for 5 min. The embryos were then
resuspended in 1 ml of protease solution [0.07 mg/ml of liberase in
Dulbecco’s PBS (DPBS); Thermo Fisher Scientific] with 0.4 U/ml DNAse I
(Invitrogen). The embryos were dissociated at 28°C for 10 min on a rotator
(or until the embryos appeared visually digested to a single cell solution),
pipetting up and down with a 200 ml tip every 4-5 min. The reaction was
stopped by placing the cell solution on ice and adding CaCl2 to a final
concentration of 1-2 mMwith 0.5% fetal bovine serum (FBS) in DPBS. The
cells were centrifuged at 2000 rpm for 5 min at 4°C, the supernatant was
discarded, and the pellet resuspended in 1 ml resuspension solution (DPBS
with 2 mM EDTA, 0.4 U/ml DNAseI and 0.5% FBS) to avoid cells
clumping together. The cells were passed through a 40 μM strainer into to a
50 ml falcon tube, following a pre-wash of the strainer with 500 μl of the
resuspension solution. Another 500 μl of the resuspension solution was
added to the filter to remove any remaining cells. The cells were centrifuged
at 2000 rpm for 5 min at 4°C and resuspended in 500 μl of DPBS+EDTA
solution. The cell solution was transferred to a 5 ml polypropylene (Falcon)
dedicated test tube and kept on ice until sorting with a FACSAria™ III
Sorter (BD). Cells were sorted and filtered against triplets and droplets.
Negative control cells from negative nEGFP siblings were used to define the
GFP+ collection window, to filter against auto-fluorescence. nEGFP-
positive and -negative cells from green Tg[fli1a:nEGFP]y7 embryos were
collected in different 1.5 ml Eppendorf tubes with 350 μl Trizol.
RNA extraction
The cell lysis suspension was vortexed for 15 s, spun down and incubated at
room temperature for 5 min and 0.5 μl glycoblue, a nucleic acid
coprecipitant, was added to the lysed solution to aid visualization of the
precipitated RNA. Then 50 μl chloroform was added to each tube, the tubes
were shaken vigorously for 15 s and incubated at room temperature for
5 min. Tubes were centrifuged at 12,000 rpm (14,489 g) for 15 min at 4°C.
RNA was present in the transparent supernatant. The supernatant was
carefully pipetted to a LoBind Eppendorf tube, with 125 μl added to the
aqueous phase and the tube shaken vigorously for 15 s. The solution was
incubated at −20°C overnight. The solution was then centrifuged at
12,000 rpm for 10 min at 4°C. The supernatant was then removed, leaving
the small blue RNA pellet, which was washed with 500 μl of 75% ethanol,
shaken and centrifuged at 7500 rpm (5660 g) for 5 min at 4°C. The
supernatant was discarded and the pellet air dried until no liquid was left. The
pellet was resuspended in 13 μl of DEPC-treated water and the concentration
and purity were measured using a Nanodrop 2000 (Thermo Fisher Scientific),
and the reverse transcription was carried out for samples presenting with an
RNA concentration above 20 ng/μl and a 260/280 purity higher than 1.8
using the Superscript IV First-Strand cDNA synthesis reaction kit (Thermo
Fisher Scientific) and random hexamer primers. The reaction was incubated
for 1 h. The final reaction was diluted at 1:10 and kept at −20°C.
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The primers were designed using Primer blast (http://www.ncbi.nlm.nih.
gov/tools/primer-blast/) to have a melting temperature of 60°C and to span
exon-exon junctions to avoid amplification of genomic DNA. Each reaction
was set in a 20 μl volume mix containing 10 μl of SYBR-green qPCR mix
(Roboklon), 0.8 μl cDNA (1:50 dilution), 0.45 μl of carboxyrhodamine
(ROX) and 0.25 μl uracil-N-glycosylase (UNG) from Roboklon and primers
to a final concentration of 300 μM. Three technical replicates of each sample
were used. Amplification was performed in triplicates in 384-well plates
(Applied Biosystems) with the following thermal cycling conditions: initial
uracil-DNA glycosylase (UDG) treatment 50°C for 10 min, followed by 40
cycles of 15 s at 95°C and 60 s at 60°C. Control reactions included a no
template control (NTC). qPCR was performed using a Quantstudio6Flex
machine (Life Technologies). Amplification curves were analysed to
confirm the presence of a single PCR product, and outliers excluded
when one of the Ct values was very different from the other two. qPCR data
was analysed using the Pfaff method (Pfaffl, 2001) that integrates primer
amplification efficiency, determined by LinReg software (Ruijter et al.,
2009). Samples were normalised against four endothelial housekeeping
genes: rpl13, rps29, hprt1 and eef1a1l1. The geometric average of the
housekeeping genes was used for normalization of gene expression (Coxam
et al., 2014). Three replicates of the qPCR were carried out. Primers used
were: vash1-1 fw GGGACATGAGGCTCAAGATTGG, rev GTCGCTC-
TGGCTGTTCTTGC; vash1-2 fw ATCATTAACAGGGGCGGCCT, rev
GGTACTGGAATCTTGGGCAGGT; rpl13 fw CATCTCTGTTGACTC-
ACGTCG, rev CATCTTGAGCTCCTCCTCAGTAC; rps29 fw TTTGCT-
CAAACCGTCACGGA, rev ACTCGTTTAATCCAGCTTGAC; hprt1 fw
ATCATGGACCGAACTGAACG, rev AGCGATCACTGTTGCGATTA;
eef1a1l1 fw CTGGAGGCCAGCTCAAACAT, rev ATCAAGAAGAGTA-
GTACCGCTAGCATTAC.
Protein extraction for protein analysis
We dechorionated 35 embryos by adding pronase (1 mg/ml) and
anaesthetising with 0.16 mg/ml tricaine methanesulfonate (Sigma-
Aldrich). Yolk sacs were removed with two rounds of centrifugation in
Calcium ringer solution at 2000 rpm (400 g) at 4°C for 5 min each and all
liquid was removed until only a dry pellet of embryos was left in the tube.
Pellets were fast frozen with liquid nitrogen and kept at −80°C for at least
20 min. The protein extraction procedure included adding 40 μl of lysis
buffer (1 M Tris-HCl, 0.5 M EDTA, 10% Brij 96, 10%NP-40) and 0.4 μl of
protease inhibitor cocktail (Thermo Fisher Scientific), homogenization with
a pestle (Starlab) and centrifugation at 4°C for 15 min. The concentration of
the protein extracts was measured using the BCA protein assay kit (Thermo
Fisher Scientific).
Western blot
Wemixed 50 μg of the lysates with reducing sample buffer (1:4) and heated
the mixture for 5 min at 95°C to denature proteins. The proteins were
electrophoresed for 1 h at 150 V and subsequently transferred onto MtOH
activated polyvinylidene fluoride membranes (GE Healthcare). Equal
loading was assessed using Ponceau Red solution. Membranes were
blocked with blocking solution [5% non-fat dry milk in Tris-buffered saline
with 0.1% Tween® 20 detergent (TBS-T)] for 1.5 h at room temperature and
then incubated with primary antibody against Vash1 (1:500, Proteintech,
12730-1-AP) overnight at 4°C. After incubation with primary antibody, the
membranes were washed four times in TBS-T and then incubated with a
secondary antibody for 1 h at room temperature (ECL anti-rabbit IgG HRP,
1:4000; GE Healthcare, #NA934V) and washed three times with TBS-T.
Immunodetection was performed using a chemiluminescence kit
(SuperSignal West Dura; Pierce), and bands were developed using the
Las-4000 imaging system (Thermo Fisher Scientific). After initial
immunodetection, membranes were stripped of antibodies using the
Stripping kit (Thermo Fisher Scientific) at 56°C for 40 min and re-probed
with anti-β-actin antibody for 1 h (1:1000, Sigma-Aldrich, A5441). The
membranes were washed in TBS-T and incubated for 3 h at room
temperature with a secondary antibody (ECL anti-mouse IgG HRP, 1:5000,
GEHealthcare, #NA931V). Three replicates of experiments per western blot
were performed.
Morpholino experiments
Themorpholino against plcγwas used as previously described (Hogan et al.,
2009a). Upon injection with morpholinos targeting Vash1, a portion of the
embryos is morphologically aberrant (Fig. S1E,F). Only embryos with
normal looking morphology were taken for further analysis (Fig. S1A-D).
Dosage curves were used to find the appropriate dosage for injection
(indicated below; Fig. S1E,G,H,I).
The injection mix used 0.4% phenol red, and 1 nl was injected at the one-
cell stage. The amount of control MO injected was the same as the total
amount of experimental MO injected. vash1 morpholino 1, 5′-ATTAAT-
CTGAGGAGCACACGGCAGT-3′ (3 ng injected); vash1 morpholino 2,
5′-GTAACTGAGCCATCGCAGGAGTTAA-3′ (5 ng injected); vash1 m-
orpholino 3, 5′-CAGGACACCGGCATCAGCAGAACAC-3′ (2 ng injec-
ted); plcγmorpholino, 5′-ATTAGCATAGGGAACTTACTTTCG-3′ (10 ng
injected); control morpholino, 5′-CCTCTTACCTCAGTTACAATTTATA-
3′ (same as experimental MOs).
Rescue experiment
vash1 full-length cDNA (EMSEMBL ENSDART00000143819.3) was
designed and synthesised by GenScript. TA overhangs were added by
incubating the insert for 10 min at 72°C with 50 mM DNTPs and Taq
polymerase (New England Biolabs), in order to perform TA cloning into a
PCR4TOPO vector (Thermo Fisher Scientific). Integrationwas confirmed by
sequencing. In order to transcribe the cDNA into RNA, the construct was
linearized using NotI and the cDNAwas transcribed for 4 h byMegascript kit
(Life Technologies) using the T3 promoter. The RNA was purified by
lithium-chloride precipitation to a concentration of 500 ng/μl. Aliquots were
kept at −80°C until further use. For rescue experiments, 1 nl of 150 pg RNA
was injected into embryos already injectedwithMOs against vash1 or control.
CRISPR/Cas mutagenesis
The target specific Alt-R CRISPR RNA (crRNA) was designed and ordered
at https://eu.idtdna.com/, to target exon 4 of vash1, in which two codons
translate into lysine (L168) and cysteine (169C), crucial for the
carboxypeptidase function of Vash1 (Adamopoulos et al., 2019). The
crRNA was annealed with the common Alt-R transactivating crRNA
(tracrRNA) from IdtDNA, as previously described (Hoshijima et al., 2019).
To synthesize spCas9 protein, a pET-28b-Cas9-His plasmid (Addgene
plasmid #47327) was transformed intoEscherichia coliRosetta(DE3)pLysS
cells (Merck Millipore, 70956-3). Cells were pelleted incrementally at
4000 rpm (3041 g) at 4°C for 10 min. The pellet was resuspended in 30 ml
wash buffer. Cells were sonicated for 3× 15 s with a break of 1 min each
time at cycle five, amplitude 92%. The resulting cell suspension was
centrifuged for 1 h at 14,000 rpm (37,252 g) to pellet the cell debris. The
His-tagged Cas9 was extracted using nickel resin columns.
The injection mix was composed of 1 μl 25 μM gRNA (targeting vash1
or universal control), 1 μl 25 μMCas9 stock, 1.75 μl H2O, 0.75 μl 2 M KCl
and 1 μl 0.25% Phenol Red solution. Before microinjection, the solution
was incubated at 37°C for 5 min and then placed on ice, and then ∼1 nl was
injected. The crRNA targeting exon 4 of vash1 was ATCTCTGCCAATC-
AAGTGTTT, and the universal guide RNA (Wierson et al., 2020) was
GGGAGGCGTTCGGGCCACAGCGG
Genotyping
DgRNA- and Cas9-injected embryos were imaged using the confocal
spinning disk microscope at 52 hpf for PL phenotyping, as previously
described. Afterwards, genomic DNA was extracted from individual
embryos at 2 dpf: dechorionated embryos were incubated in 40 μl 50 mM
NaOH at 95°C for 10 min. After cooling to 4°C, 13.6 μl of 0.5 M Tris-HCl
(pH 8.0) was added to neutralize. A PCR with forward (ATCTCTGCCA-
ATCAAGTGTTT) and reverse (AGCAGCACATTTCACTGCAGA)
primers was performed, as well as an incubation of 8 min at 72°C with a
Taq polymerase to add AAA overhangs. The PCR products were
subsequently confirmed in an agarose gel, gel-purified using a Promega
DNA clean-up and concentration kit (#A2893) and TA-cloned into a PCR4
vector. To understand the frequency of mutated cells in a single embryo, five
clones per embryo were sequenced.
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The Qtracker 705 quantum dots solution (Invitrogen, Q21061MP) was
injected in the heart of 4 dpf zebrafish embryos anaesthetized with 0.014%
tricaine and mounted laterally in 0.8% low-melting agarose. The quantum
dots were excited with a 561 nm laser and their emission detected between
665.5 and 735.5 nm. For all quantifications, a minimum of three biological
replicates were used.
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